RT Journal Article
SR Electronic
T1 Plasma lipidomics identifies a signature of NAFLD in children that couples with cardiometabolic outcomes in adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.18.20070417
DO 10.1101/2020.04.18.20070417
A1 Mann, Jake P.
A1 Jenkins, Benjamin
A1 Furse, Samuel
A1 Snowden, Stuart G.
A1 Alisi, Anna
A1 Draijer, Laura G.
A1 ,
A1 Karnebeek, Kylie
A1 Kelly, Deirdre A.
A1 Koot, Bart G.
A1 Mosca, Antonella
A1 Salvestrini, Camilla
A1 van Mourik, Indra
A1 Vreugdenhil, Anita
A1 Zilbauer, Matthias
A1 Koulman, Albert
YR 2021
UL http://medrxiv.org/content/early/2021/09/17/2020.04.18.20070417.abstract
AB Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition in children and adults characterized by insulin resistance and altered lipid metabolism. Affected patients are at increased risk of cardiovascular disease (CVD) and children with NAFLD are likely to be at risk of premature cardiac events. Evaluation of the plasma lipid profile of children with NAFLD offers the opportunity to investigate these perturbations and understand how closely they mimic the changes seen in adults with cardiometabolic disease. We hypothesized that change in the concentration of lipid species in pediatric NAFLD would mimic the alterations known to be associated with CVD in adults (and be largely reflective of insulin resistance). Here, we performed untargeted liquid chromatography mass spectrometry (LC-MS) plasma lipidomics on 287 children: 19 lean controls, 146 from an obese cohort, and 122 NAFLD cases who had undergone liver biopsy. Associations between lipid species and liver histology were assessed using regression adjusted for age and sex. Results were then replicated using data from 9,500 adults with metabolic phenotyping. Phosphatidylcholine (PC) and triglyceride (TG) desaturation and chain length were inversely associated with histological severity of paediatric NAFLD. Nine lipids species (lyso-PC, PC, and TG classes) were also associated with hepatic steatosis and insulin resistance in an independent cohort of adults. Five of the 9 lipids replicated in the adults cohort (including PC(36:4)) have been directly linked to death and cardiometabolic disease in adults, as well as indirectly via genetic variants that influence the concentration of these species. Together, these findings suggest that lipid metabolism is altered in paediatric NAFLD in a similar way as in cardiometabolic disease in adults and it is therefore critical to alleviate insulin resistance in these children to mitigate their long-term morbidity.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04190849Funding StatementJPM is supported by a Wellcome Trust fellowship (216329/Z/19/Z), a European Society for Paediatric Research (ESPR) Young Investigator Award, and a Childrens Liver Disease Foundation Grant. EU-PNAFLD Registry is supported by an European Association for Study of the Liver (EASL) Registry Grant. MZ is supported by a New Investigator Research Grant from the MRC (MR/T001917/1). BK is supported by grants from Van den Broek Lohman Foundation, Virtutis Opus Foundation and For Wishdom Foundation. SF, SGS & AK are supported by the BBSRC (BB/M027252/1 & BB/P028195/1), BJJ & AK are supported by the National Institute for Health Research (NIHR146281).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFull summary statistics available in supplement. Code used in analysis available from: https://doi.org/10.5281/zenodo.5507129GWASgenome-wide association studyLPClyso-phosphatidylcholineNAFLDnon-alcoholic fatty liver diseaseNASHnon-alcoholic steatohepatitisNASNAFLD Activity ScorePCphosphatidylcholinePheWASphenome-wide association studyTGtriglyceride